Cargando…

Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis

BACKGROUND: The emergence of genetically-modified human proteins and glucagon-like peptide-1 (GLP-1) receptor agonists have presented a promising strategy for effectively managing diabetes. Due to the scarcity of clinical trials focusing on the safety and efficacy of semaglutide as an adjunctive tre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Tirath, Nageeta, Fnu, Sohail, Rohab, Butt, Tooba Shaukat, Ganesan, Shyamala, Madhurita, Fnu, Ahmed, Muhammad, Zafar, Mahrukh, Zafar, Wirda, Zaman, Mohammad Uzair, Varrassi, Giustino, Khatri, Mahima, Kumar, Satesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375936/ https://www.ncbi.nlm.nih.gov/pubmed/37498865 http://dx.doi.org/10.1080/07853890.2023.2239830

Ejemplares similares

Advancements in Inflammatory Bowel Disease: A Narrative Review of Diagnostics, Management, Epidemiology, Prevalence, Patient Outcomes, Quality of Life, and Clinical Presentation
por: Muzammil, Muhammad Ali, et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis on the Efficacy and Safety of Finerenone Therapy in Patients with Cardiovascular and Chronic Kidney Diseases in Type 2 Diabetes Mellitus
por: Jyotsna, FNU, et al.
Publicado: (2023)

Charting the Progress of Epilepsy Classification: Navigating a Shifting Landscape
por: Abdelsamad, Alaa, et al.
Publicado: (2023)

Single Incision Mini-Sling Versus Mid-Urethral Sling (Transobturator/Retropubic) in Females With Stress Urinary Incontinence: A Systematic Review and Meta-Analysis
por: Patel, Tirath, et al.
Publicado: (2023)

Unlocking the Potential of Immunotherapy in Cardiovascular Disease: A Comprehensive Review of Applications and Future Directions
por: Jyotsna, FNU, et al.
Publicado: (2023)

Knowledge, Attitude, and Practice of Cigarette Smoking Among Medical Students of Quaid-E-Azam Medical College, Bahawalpur: A Web-Based Cross-Sectional Study
por: Mustafa, Nawal, et al.
Publicado: (2023)

Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes
por: Seino, Yutaka, et al.
Publicado: (2017)

Integrative Medicine Approaches: Bridging the Gap Between Conventional and Renal Complementary Therapies
por: Kalariya, Yash, et al.
Publicado: (2023)

Advancements in Heart Failure Management: A Comprehensive Narrative Review of Emerging Therapies
por: Sapna, FNU, et al.
Publicado: (2023)

Precision Medicine Approaches to Diabetic Kidney Disease: Personalized Interventions on the Horizon
por: Nageeta, FNU, et al.
Publicado: (2023)

The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
por: Vidal, Josep, et al.
Publicado: (2020)

Efficacy and safety of once‐weekly semaglutide versus once‐daily sitagliptin as add‐on to metformin in patients with type 2 diabetes in SUSTAIN China: A 30‐week, double‐blind, phase 3a, randomized trial
por: Ji, Linong, et al.
Publicado: (2021)

Advances in the Management of Diabetes Mellitus: A Focus on Personalized Medicine
por: Sugandh, FNU, et al.
Publicado: (2023)

Deciphering the Dilemma: Anticoagulation for Heart Failure With Preserved Ejection Fraction (HFpEF)
por: Jyotsna, FNU, et al.
Publicado: (2023)

Respiratory Dysfunction in Epileptic Encephalopathies: Insights and Challenges
por: Khan, Muhammad Ali, et al.
Publicado: (2023)

Clinical Outcomes of Polymer-Free Versus Polymer-Coated Drug-Eluting Stents in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Khatri, Mahima, et al.
Publicado: (2023)

Innovative Approaches and Therapies to Enhance Neuroplasticity and Promote Recovery in Patients With Neurological Disorders: A Narrative Review
por: Kumar, Jitesh, et al.
Publicado: (2023)

The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
por: Kotak, Sohny, et al.
Publicado: (2023)

Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
por: Johansen, Pierre, et al.
Publicado: (2019)

Different Effects of Once-weekly and Once-daily Administered GLP-1RA Semaglutide and Liraglutide on Bile Acid Diarrhea
por: Kårhus, Martin Lund, et al.
Publicado: (2022)

Comparative Efficacy and Safety Profiles of High-power, Short-duration and Low-power, Long-duration Radiofrequency Ablation in Atrial Fibrillation: A Systematic Review and Meta-analysis
por: Kumar, Satesh, et al.
Publicado: (2023)

Comment on: Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis
por: Zafar, Wirda, et al.
Publicado: (2023)

Seizing the Connection: Exploring the Interplay Between Epilepsy and Glycemic Control in Diabetes Management
por: Nadeem, Muhammad Daniyal, et al.
Publicado: (2023)

Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes in the UK
por: Johansen, Pierre, et al.
Publicado: (2020)

Advancements in Myocardial Infarction Management: Exploring Novel Approaches and Strategies
por: Sachdeva, Pranav, et al.
Publicado: (2023)

Once-Weekly Semaglutide Versus Once-Daily Liraglutide for the Treatment of Type 2 Diabetes: A Long-Term Cost-Effectiveness Analysis in Estonia
por: Malkin, Samuel J. P., et al.
Publicado: (2018)

Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways
por: Zakir, Mehreen, et al.
Publicado: (2023)

Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis
por: Carlsson Petri, Kristin Cecilie, et al.
Publicado: (2018)

Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
por: Hunt, Barnaby, et al.
Publicado: (2019)

Once-weekly 2.4 mg Semaglutide for Weight Management in Obesity: A Game Changer?
por: Colin, Ides M, et al.
Publicado: (2022)

Exploring the Complex Connection Between Diabetes and Cardiovascular Disease: Analyzing Approaches to Mitigate Cardiovascular Risk in Patients With Diabetes
por: Jyotsna, FNU, et al.
Publicado: (2023)

Advancements in the Management of Endocrine System Disorders and Arrhythmias: A Comprehensive Narrative Review
por: Kumari, Yogita, et al.
Publicado: (2023)

Exploring the Effectiveness and Safety of Azilsartan-Medoxomil/Chlorthalidone Versus Olmesartan-Medoxomil/Hydrochlorothiazide in Hypertensive Patients: A Meta-Analysis
por: Kumar, Lakshya, et al.
Publicado: (2023)

Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial
por: McCrimmon, Rory J., et al.
Publicado: (2020)

Real-World Use of Once-Weekly Semaglutide in Type 2 Diabetes: Results from SemaglUtide Real-world Evidence (SURE) Germany
por: Menzen, Markus, et al.
Publicado: (2023)

Public Knowledge About COVID-19 Booster Vaccines in Pakistan: A Study Conducted in a Tertiary Care Hospital in Karachi
por: Khan, Misha, et al.
Publicado: (2023)

Improved treatment satisfaction in patients with type 2 diabetes treated with once‐weekly semaglutide in the SUSTAIN trials
por: Jendle, Johan, et al.
Publicado: (2019)

Correction: Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
Publicado: (2020)

Real-world use of once-weekly semaglutide in patients with type 2 diabetes at an outpatient clinic in Spain
por: Garcia de Lucas, Maria Dolores, et al.
Publicado: (2022)

Cardiac Rehabilitation in the Modern Era: Optimizing Recovery and Reducing Recurrence
por: Zaree, Amna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qr5uunc94bhbpu1ptcojmnlu0o